Bioorganic and Medicinal Chemistry Letters p. 1231 - 1236 (1998)
Update date:2022-08-03
Topics:
Gleave, D. Mark
Brickner, Steven J.
Manninen, Peter R.
Allwine, Debra A.
Lovasz, Kristine D.
Rohrer, Douglas C.
Tucker, John A.
Zurenko, Gary E.
Ford, Charles W.
A series of conformationally restricted, [6,5,5] and [6,6,5] tricyclic fused oxazolidinones were synthesized and tested for antibacterial activity. Several compounds in the trans-[6,5,5] series demonstrated potent in vitro and in vivo activity. This work provides valuable information regarding the preferred conformational orientation of the oxazolidinones at the binding site.
View MoreChangyi Xinxing Technology Development Co., Ltd.
Contact:0086-510-86651065(Time Zone:8),86651656
Address:94 Yingbinxilu WestRoad, Huangtu Town, Jiangyin City, Jiangsu, China
Contact:+86-512-69561895
Address:No.111, Building A4, 218 Xinghu Street, Suzhou Industrial Park, P. R. China
Shandong Green Bio-Pharmaceutical Co.,Ltd
Contact:+86-530-5408622
Address:High-tech Development Zone, Heze City, Shandong, China
BrightGene Bio-Medical Technology Co., Ltd.
website:https://en.bright-gene.com/
Contact:+86-512-62551801
Address:Building C25 - C31, No. 218 Xinghu Road, Suzhou Industrial Park, Suzhou, Jiangsu, China.
Contact:+86-519-86339586，13584329896
Address:Changzhou Scientific and Education Park
Doi:10.1016/S0040-4039(02)00857-2
(2002)Doi:10.1021/om980035w
(1998)Doi:10.1016/j.bmcl.2004.02.071
(2004)Doi:10.1021/acs.orglett.5b00295
(2015)Doi:10.1016/S0022-328X(97)00720-1
(1998)Doi:10.1021/jo980367a
(1998)
